ライフサイエンスコーパス: laboratory result

1 c group had > or = 1 abnormal metabolic bone laboratory result.

2 gave a false-positive Blastomyces DNA probe laboratory result.

3 s included by randomised group if they had a laboratory result.

4 interpretation of clinical presentation and laboratory results.

5 no change in heart rate, blood pressure, or laboratory results.

6 volved in meningococcal screening can regard laboratory results.

7 glucosan decay with kinetics consistent with laboratory results.

8 s (92.5%), unstable vital signs and abnormal laboratory results.

9 yle factors, comorbidities, medications, and laboratory results.

10 lower predictive value than vital signs and laboratory results.

11 mographic information and commonly available laboratory results.

12 atients including age, BMI, vital signs, and laboratory results.

13 tion, potentially affecting comparability of laboratory results.

14 related to demographics, clinical data, and laboratory results.

15 al information and cerebrospinal fluid (CSF) laboratory results.

16 re, clinical and obstetric presentation, and laboratory results.

17 sterol (n = 96,155) and glucose (n = 81,599) laboratory results.

18 on demographics, clinical presentation, and laboratory results.

19 d for demographic data, ocular findings, and laboratory results.

20 recurrent angioedema in patients with normal laboratory results.

21 symptoms, physical examination findings, and laboratory results.

22 a (p < 10) when comparing meter results with laboratory results.

23 ed using a phase-field model and compared to laboratory results.

24 fection based on clinical, radiographic, and laboratory results.

25 or the other compounds also agreed well with laboratory results.

26 requirements for negative hepatitis A and B laboratory results.

27 h Revision codes, pharmaceutical claims, and laboratory results.

28 DI, assuming patient management according to laboratory results.

29 etabolic risk factors, mobilizable iron, and laboratory results.

30 where patients may fail to return for their laboratory results.

31 ory using MI diagnoses and/or cardiac enzyme laboratory results (1995-2012).

32 0 mIU/L) TSH level using the first available laboratory result 6 weeks to 12 months after the index d

33 Based on the laboratory results, a new phase diagram for microplastic

34 including extrema values for vital signs and laboratory results, admission diagnosis, the Glasgow Com

35 erity at presentation, patient demographics, laboratory results, admission location, and other clinic

36 e, infectious diagnoses, and microbiological laboratory results among hospitalized patients and aim t

37 ory, presenting clinical signs and symptoms, laboratory results, ancillary (including molecular genet

38 Using automated laboratory result and clinical data from two United Stat

39 the acceptable level of agreement between a laboratory result and the assigned value for a given ser

40 Additional outcomes included abnormal laboratory results and adverse events proximate to MRA i

41 A much better correlation between laboratory results and anamnesis and skin tests was achi

42 Both laboratory results and CT angiography revealed aortoesop

43 demographics, chronic diagnoses, vitals, and laboratory results and determined the impact of delay on

44 tpatient diagnosis codes, as well as data on laboratory results and dispensing of antidiabetic medica

45 The broad concordance shown here between laboratory results and extensive field data suggests tha

46 the effect of the intervention on changes in laboratory results and healthcare utilization over a six

47 concern based on objective measures, such as laboratory results and imaging findings.

48 Laboratory results and MELD scores were pooled to calcul

49 b-browser, others revealed disparity between laboratory results and online results.

50 A patient navigator reviews laboratory results and provides counseling in the OTP cl

51 the clinical symptoms, duration of illness, laboratory results and pulmonary function tests (PFT).

52 tions might facilitate the interpretation of laboratory results and the clinical treatment of these p

53 ndatory public health reporting of influenza laboratory results and vaccine doses administered in the

54 code or positive orthopoxvirus or mpox virus laboratory result, and control patients had an incident

55 We reviewed medical records, laboratory results, and autopsy findings and performed w

56 Clinical records, laboratory results, and chest CT scans were retrospectiv

57 r presenting symptoms, physical examination, laboratory results, and chest radiographs.

58 d included demographics, signs and symptoms, laboratory results, and clinical outcome for foodborne a

59 Clinical records, laboratory results, and CT scans were retrospectively an

60 l signs and symptoms, male gender, admission laboratory results, and diabetes were the most important

61 Disease course, laboratory results, and imaging findings were extracted.

62 ety of clinical data, including vital signs, laboratory results, and imaging findings, ML models can

63 Data on clinical presentation, laboratory results, and KIT sequencing from skin biopsie

64 etween health worker and patient, outcome of laboratory results, and medicine availability.

65 t included 1,420,596 clinical notes, 387,392 laboratory results, and more than 1505 laboratory test i

66 ir first recorded vital signs, observations, laboratory results, and other predictors documented in t

67 Demographics, medical histories, admission laboratory results, and outcomes were captured from the

68 Clinical characteristics, laboratory results, and pharmacy data were extracted fro

69 Patient age, hospital unit, vital signs, laboratory results, and prior comorbidities were used to

70 e events, vital signs, electrocardiogram and laboratory results, and scores on the Extrapyramidal Sym

71 mortality based on clinical characteristics, laboratory results, and severity scores.

72 nt demographics, comorbidities, preoperative laboratory results, and surgery details were obtained fr

73 thms and using diagnosis codes, medications, laboratory results, and survey data, we developed and im

74 to therapy with ursodeoxycholic acid (UDCA), laboratory results, and symptom impact (assessed using t

75 inical features, histopathological findings, laboratory results, and treatment of 3 patients with an

76 Safety assessments included adverse events, laboratory results, and vestibular testing.

77 sit and the ability to contact patients when laboratory results are available.

78 bility is established appropriately and that laboratory results are comparable.

79 These laboratory results are in general agreement with full-sc

80 Mpox cases and positive laboratory results are reported to Toronto Public Health

81 t types and tectonic/induced settings, while laboratory results are unaffected by loading protocol or

82 Our preliminary wet laboratory results are very encouraging and we believe t

83 Using laboratory results as a reference standard, phenotypes u

84 Using laboratory results as gold standard, DAD had a sensitivi

85 forms to configure, organize, and distribute laboratory results as well as minimizing cost.

86 Clinical and laboratory results associated with injury were identifie

87 rs, with more than 1000 IU/mL HCV RNA, and a laboratory result at screening indicating infection with

88 nderwent ECG within 2 h prior to a serum TnI laboratory result at the University of California, San F

89 and other clinical features, by integrating laboratory results, biomarkers, and imaging.

90 orithm not only showed good consistency with laboratory results but also revealed useful information,

91 in animals and humans before these promising laboratory results can be applied in clinical practice.

92 that a simple index using readily available laboratory results can identify CHC patients with signif

93 e nausea, progressive course of disability), laboratory results (cerebrospinal fluid (CSF) pleocytosi

94 Demographic information, laboratory results, charted data, discharge diagnoses, p

95 demographics, physical signs, comorbidities, laboratory results, clinical events, and the Confusion,

96 Covariates were demographic data, laboratory results, comorbidities, and hospital stays.

97 Presence of HSV IgM in absence of other laboratory results could be enough evidence to start HSV

98 cal Modification codes cross-referenced with laboratory results detecting LACV.

99 d COVID-19 infection evidenced by a relevant laboratory result, diagnosis, or prescription order.

100 mptoms, as well as by physical examinations, laboratory results, echocardiograms, electrocardiograms,

101 g baseline characteristics + vital signs and laboratory results + echocardiographic measurements.

102 Most often, inexplicable laboratory results established the diagnosis.

103 letter (AL) including information on FH, if laboratory results exceeded thresholds as follows: adult

104 lycemia during follow-up, determined by: (1) laboratory results (fasting/2-h postload/random glucose

105 Case reports include clinical information, laboratory results, fetal or neonatal organ histology an

106 reviewed to determine patient demographics, laboratory results, findings on colonoscopy and histopat

107 Observed deviation of a laboratory result for a PT sample must be entirely attri

108 lated with all clinical data including other laboratory results for a given patient.

109 ort study analyzed administrative claims and laboratory results for adults (aged 18 years) with type

110 s were highly correlated (r values) with the laboratory results for CP (0.85), NDF (- 0.76), ADF (- 0

111 ting multimodal data from clinical notes and laboratory results for diabetes risk prediction.

112 nical and exposure history when interpreting laboratory results for diagnostic and surveillance purpo

113 IP) identified cases through surveillance of laboratory results for hospitalized children and adults.

114 specific neuroimaging findings, and negative laboratory results for other congenital infections; mode

115 A postmortem autopsy revealed positive laboratory results for syphilis, which was corroborated

116 igation strategies, MD1003 led to inaccurate laboratory results for tests using biotinylated antibodi

117 is report, we describe clinical symptoms and laboratory results for unvaccinated individuals with acu

118 to five categories based on neuroimaging and laboratory results for Zika virus and other relevant inf

119 rome (ADCLS), in which diagnosis is based on laboratory results from a nonreference Lyme specialty la

120 c data, physiological clinical variables and laboratory results from electronic healthcare records (E

121 emographics, comorbidities, medications, and laboratory results from symptomatic and surveillance gro

122 ng a standardized case-report form linked to laboratory results from the Centers for Disease Control

123 cs, risk factors, and standard of care (SOC) laboratory results from the medical records were recorde

124 r results with near simultaneously performed laboratory results from the same patient by applying the

125 Together, the field and laboratory results from this study showed that the biode

126 , admission source (direct or transfer), and laboratory results (from the +/- 24-hr period surroundin

127 67-year-old woman's clinical findings, laboratory results, fundus fluorescein angiography, opti

128 ata from imaging, electronic health records, laboratory results, genomics, graphs or medical text.

129 Laboratory results highlighted elevated serum IgG4 level

130 Clinical response, adverse events, laboratory results, imaging and liver biopsies were retr

131 ative effort between the Steinman and Sekaly laboratories resulted in a paper published in this issue

132 Recent efforts from the Abbott Laboratories resulted in the development of the acylsulf

133 Previous work in our laboratories resulted in the purification of arginine- a

134 diagnosis is now highly centralized in large laboratories, resulting in low access to patient monitor

135 Previous studies by our laboratory resulted in the discovery that increasing alk

136 ations of the allosteric mechanism from this laboratory resulted in the postulation of a model consis

137 Mental stress in the laboratory results in a substantial sympathetic response

138 One of the best-known and most replicated laboratory results in behavioral economics is that barga

139 tations of the PCR test, and of interpreting laboratory results in context of clinical disease.

140 Co-located processing at Oak Ridge National Laboratory results in curium contamination of the fissio

141 Nonlaboratory-trained individuals can obtain laboratory results in the critical care setting comparab

142 hlamydia and gonorrhea were defined based on laboratory results in the electronic health record.

143 enges with interpreting body composition and laboratory results in the setting of volume overload and

144 Feature vectors for laboratory results included 702 features total derived f

145 We collected clinical characteristics, laboratory results (including the results of tests for a

146 blic health efforts require comparability of laboratory results independent of time, place, and measu

147 2016, to December 31, 2022, with an HBV DNA laboratory result (index date), measurement of alanine a

148 strated appropriate physical properties, and laboratory results indicated high cell viability and low

149 Previous laboratory results indicated that beetles were more like

150 Laboratory results indicated that eight albinos (includi

151 We used laboratory results, International Classification of Dise

152 to have CDI, their isolation while awaiting laboratory results is costly.

153 The encouraging clinical and laboratory results justify the current plans for a phase

154 Combinations of certain symptoms, signs, and laboratory results likely have more useful LRs, and pres

155 his report, we describe the clinical course, laboratory results, liver pathology, and treatment of 2

156 uantitative multimarker testing versus local laboratory results (LL) in 1005 patients in 6 chest pain

157 in-technique agreement, with the majority of laboratories' results lying within 1 sd of their consens

158 the history, physical examination, and basic laboratory results make toward the diagnosis, prognosis,

159 These clinical findings with the appropriate laboratory results make up the antiphospholipid antibody

160 veraging a broad set of features for patient laboratory results, medications, and the surgical proced

161 The model integrates vital signs, laboratory results, medications, assessment scores, and

162 talization, controlling for medical history, laboratory results, medications, HF disease severity, an

163 Cases in which patients with negative laboratory results met diagnostic and clinical criteria

164 ed on postoperative surveillance imaging and laboratory results, no patient had evidence of recalcitr

165 e expression patterns, clinical factors, and laboratory results obtained at diagnosis and at 1 and 3

166 review the technical developments and early laboratory results obtained with radio-frequency ablatio

167 Analysis of the laboratory results of Aregahegn et al. (2013) suggests t

168 e community-based medical records, including laboratory results, of all Rochester, Minnesota, residen

169 infant deaths with verbal autopsies and RSV laboratory results, of which 62 results were positive.

170 Laboratory results on the 1st day of hospitalization sho

171 Laboratory results on the 1st day of hospitalization sho

172 no changes in heart rate, blood pressure, or laboratory results) on any of the subjects.

173 ed by confirmation of influenza infection by laboratory results or death certificates.

174 ly significant abnormalities in vital signs, laboratory results, or electrocardiogram findings were i

175 yzed the link between clinical presentation, laboratory results, outcome and etiology.

176 mptoms suggestive of Lyme disease with other laboratory results positive for B. burgdorferi (n = 1).

177 atient presentations including 4,945 audited laboratory results, presenters used a paper prerounding

178 Laboratory results, psychological symptom reports, and r

179 e registry, including case report forms, CDC laboratory results, published case reports, and media in

180 come and other measures of disease activity, laboratory results, quality of life and functional statu

181 , OFC, and aripiprazole), abnormal metabolic laboratory results (quetiapine and OFC), and weight gain

182 D diagnosis at baseline and at least 1 HbA1c laboratory result recorded within 3 months before treatm

183 ion, intensive care, respiratory support, or laboratory results related to pertactin expression.

184 HCV laboratory results reported to the Philadelphia Departme

185 Patient characteristics, diagnoses, and laboratory results representing metabolism and liver fun

186 Interpretation of these clinical laboratory results requires knowledge of the performance

187 Clinical data, including age of onset, laboratory results, response to treatment, kidney biopsy

188 Laboratory results scaled to 4-36 in.

189 d a system in place for rapid communication; laboratory results should be delivered to physicians wit

190 Our laboratory results show that under a high humidity and l

191 The inter-laboratory results showed at least 94% correct results f

192 Laboratory results showed high angiotensin converting en

193 Laboratory results showed that BPH was unable to complet

194 holism or chronic lung disease, and abnormal laboratory results such as elevated liver aminotransfera

195 rs of a patient's oxygen supply and selected laboratory results, such as blood lactate and creatinine

196 Recent laboratory results suggest that powdered activated carbo

197 Our laboratory results suggest that some of these fungicides

198 Laboratory results supported field observations that lig

199 mance, there remains a gap between promising laboratory results that usually require nano-structured

200 On the basis of any positive laboratory result, the estimated annual incidence of per

201 large U.S. administrative database linked to laboratory results, the authors identified 9,769 patient

202 demographic information, signs and symptoms, laboratory results, thoracostomy tube output, treatment

203 r treatment guidelines, and cannot interpret laboratory results, thus posing a serious risk to the he

204 The addition of POA codes and numerical laboratory results to ADM was associated with substantia

205 nal Consortium for Harmonization of Clinical Laboratory Results to coordinate harmonization efforts.

206 in structural design or the extrapolation of laboratory results to geophysical field scales.

207 bioassay experiments, extrapolation of these laboratory results to natural conditions is not straight

208 , provide greater impetus for translation of laboratory results to the field.

209 is network is to provide timely and accurate laboratory results to the Global Polio Eradication Initi

210 s of history, signalment, clinical signs and laboratory results, using published guidelines, comprisi

211 We examined validated clinical diagnoses, laboratory results, vaccine data, and patient reported o

212 ogins (mean [SD], 5.9 [11.4] vs 6.8 [14.1]), laboratory results viewed (mean [SD], 0.7 [2.7] vs 1.1 [

213 Portal registration and use (logins, laboratory results viewed, clinical notes viewed, visits

214 Laboratory results, vital signs, and demographics were u

215 Pharmacists review laboratory results/vital signs, perform medication recon

216 icant difference in comorbidities or initial laboratory results was observed between the two groups.

217 Adverse events (AEs) and abnormal laboratory results were analyzed per 100 patient-years i

218 Multiple laboratory results were atypical for toxoplasmosis, incl

219 ximately 9000 cases and controls, analyzable laboratory results were available for >/=96% of core spe

220 Vital signs and laboratory results were collected before, during, and af

221 , heart failure profile, medication use, and laboratory results were collected.

222 Clinical and laboratory results were compared with those of 17 untrea

223 Data on the use of medication and laboratory results were evaluated.

224 To further confirm if the laboratory results were evidenced in the field, the 16S

225 Abnormal laboratory results were found for 8 patients.

226 These laboratory results were further validated by performing

227 All other pertinent laboratory results were noncontributory.

228 No drug-related adverse events or abnormal laboratory results were noted except for a transient inc

229 ed; no significant changes in vital signs or laboratory results were observed.

230 he age, sex, ocular and other diagnoses, and laboratory results were reviewed in the retrospective co

231 Abnormal laboratory results were significantly raised urinary met

232 Laboratory results were within normal limits, including

233 Laboratory results were within normal limits, including

234 cular interest and expertise in microbiology laboratory results, were polled and their responses were

235 basis of history, physical examination, and laboratory results, were to be hospitalized for observat

236 We assessed correlations between these laboratory results with clinical outcomes, including hos

237 The concordance of the reference laboratory results with the results of the other two ass

238 ases (ICD) billing codes, prescriptions, and laboratory results within 90-day episodes.

239 study included accurate chart coding; having laboratory results within the searchable EMR.